Delivery Order SPE2DB20D1109-SPE2DB24FN94X
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The contract is a firm fixed-price delivery order with a ceiling value of $23,276.39 and a period of performance through April 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $12,792.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical products. This award is under an existing indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for AmerisourceBergen to deliver...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The order is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a ceiling value of $13,776.01 and a period of performance through April 8, 2024. AmerisourceBergen Drug Corporation is the prime contractor on this award, which is a task order...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $7,665.01 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical products. The delivery order has a completion date of February 1, 2024 and was awarded on January 31, 2024. This delivery order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31,...
- This is a firm fixed price delivery order award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, as the prime contractor. The award, valued at $6,182.11, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The delivery order has an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $9,615.20, is for the provision of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to support military treatment programs and facilities. The contract has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp holds an Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The contract has a ceiling value of $12,972.80 and a period of performance through August 12, 2024. This award is not set aside for any specific business category. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,096.95 firm fixed-price delivery order is for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of November 6, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The contract has a ceiling value of $1,323.60 and a period of performance through March 15, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which was issued under a larger indefinite delivery contract (IDC) awarded by DLA to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,343.13, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corporation is a for-profit organization registered in the System for Award Management...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB24FN94XDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The delivery order has a ceiling value of $22,501.20 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corporation is the prime contractor, and no set-aside was used for this award. The company also holds an Indefinite Delivery Contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of pharmaceuticals and medical supplies in support of military treatment programs and facilities worldwide. Additionally, Amerisourcebergen Drug Corporation is the prime contractor on a separate $750,000 indefinite delivery contract with the Department of Justice Federal Bureau of Investigation to provide medical supplies and prescription medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.5k | 4/5/24 |